Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Event: BioNJ to Partner with J.P. Morgan on 7th Annual BioPartnering Conference on May 23

4/14/2017

0 Comments

 
Trenton, NJ — In partnership with J.P. Morgan, BioNJ will host its Seventh Annual BioPartnering Conference on Tuesday, May 23, 2017, from 8:00 a.m. to 5:00 p.m. at the Busch Campus Center at Rutgers University in Piscataway.
 
The event is expected to bring together over 200 regional biopharmaceutical executives, investors, academic collaborators and business development professionals for a day of networking, 1-1 partnering meetings, company presentations, exhibits and plenary sessions.
 
“We’re thrilled to be partnering with J.P. Morgan on this year’s BioPartnering Conference,” said Debbie Hart, President and CEO, BioNJ.
 
“With valuable insights from J.P. Morgan, the agenda will dive into the marketplace issues, challenges and trends that are impacting deal making, financial viability and the opportunity for medical innovation,” Hart added.
​Sharing their perspectives will be J.P. Morgan executives.
 
Robert Huffines, Vice Chairman of Healthcare Banking, will kick off the day with an industry update and trends overview
 
Mr. Huffines joined J.P. Morgan in 1991 in the M&A group where he was healthcare focused. From 2002-2010, he was Co-Head of the Global Healthcare Investment Banking Group and later was promoted to Vice Chairman in 2011. In 2017, he was added to the Global Banking Management Team and named Co-Chair of the Global Strategic Advisory Council.
 
Philip Ross, M.D., Managing Director Healthcare Investment Banking Group, will moderate a panel to discuss capital raising and what now constitutes an attractive investment
 
As a client executive and key coverage partner in Healthcare Investment Banking, Dr. Ross is responsible for relationships with many of J.P. Morgan’s clients in the biotechnology industry. He also leverages his biotechnology expertise for J.P. Morgan’s global pharmaceutical coverage effort.
 
Michael Griffin, Managing Director and Investment Specialist, will lead a fireside chat with an industry research analyst
 
In his current role, Mr. Griffin is responsible for advising ultra-high net worth individuals, foundations and senior executives on a range of financial matters including asset allocation, portfolio construction, equities, fixed income and alternative investments.
 
Alma DeMetropolis, President, New Jersey Market Leadership Team and Senior Investment Specialist, will wrap up with a regional note and the day’s insights around navigating the evolving marketplace dynamics
 
Ms. DeMetropolis has been advising ultra-high net worth individuals, families, endowments and foundations on a broad range of wealth matters and managing investment portfolios for over 20 years and has been with J.P. Morgan for over 25 years. She is actively involved in leading the bank’s initiatives across New Jersey.
 
Joining this year’s exhibits will be industry liaisons from Rutgers University, Princeton University, University of Pennsylvania and New York University among other regional university research centers.
 
“Throughout the day, R&D companies will showcase their technologies and business models before an All-Star Panel of Judges,” added Hart. “It’s all about growing the ecosystem and bolstering opportunity for medical innovation.”
 
Apply by April 15 to be a company presenter. Limited presentation slots available.
 
Register by April 14 for the Early Bird rate of $250 for BioNJ, LES and NewYorkBIO Members and $300 for Future Members.
 
Contact Edie Esposito at 609-890-3185 or [email protected] to discuss exhibit and sponsorship opportunities.  Visit www.BioNJ.org to learn more.
 
BioNJ thanks its sponsors:  Amicus Therapeutics; Ashton Tweed; ContraVir Pharmaceuticals; Dynamic Strategies; EisnerAmper; Fisher Scientific; Friedman LLP; Johnson & Johnson; Merck & Co.; New Jersey Health Foundation; Law Office of Philip P. Crowley LLC; Princeton University; Rutgers, The State University of New Jersey and ThromboGenics.
 
About BioNJ
 
BioNJ, The Gateway to Health, is a network of 400 Members representing research-based life sciences companies and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount.
 
Because Patients Can’t Wait®, BioNJ supports its Members in the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society by driving capital formation, fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources.
 
For more information about BioNJ, please visit www.BioNJ.org.
 
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619